Serotoninergic systems
Serotoninergic systems
批准号:
6324758
负责人:
MICHAEL JOSEPH OWENS
金额:
$23.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2000-08-31
关键词:
Macaca mulatta age difference animal developmental psychology behavior prediction behavior test behavioral /social science research tag cerebrospinal fluid clinical depression corticotropin releasing factor disease /disorder proneness /risk early experience environmental stressor gene environment interaction hippocampus human tissue laboratory rat mother deprivation neural plasticity neurochemistry neuroendocrine system paroxetine protein localization serotonin serotonin receptor stress substance abuse related behavior
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is abundant evidence that both genetic factors and various environmental influences control the development, and ultimately the level of activity, of the adult CNS serotonergic neural systems. There is also unequivocal evidence that both genetic and environmental factors contribute to the vulnerability to many psychiatric disorders, including depression. As noted in the introduction of this CCNMD application, childhood abuse/neglect has been-established as a major risk factor in adult depression These findings suggest that both genetic and environmental influences contribute to individual differences in serotonergic function, and that this impacts upon an individual's vulnerability or resistance to develop depression or other disorders associated with altered CNS 5-HT function. In this project, we investigate the effect of adverse early experience on the development and function of the 5-HT system, utilizing two different animal models. The rodent early life stress model utilizes rats exposed to 180 min of maternal separation on postnatal days 2 to 14 as described in detail in Core B. The primate model also represents an epigenetic model described in detail in Core C; the early life stress is a variable foraging demand (VFD) on the mother reducing the amount of time she has to attend to her infant. The maternal separation and VFD stressors cause persistent changes in the CNS of adult animals as well as documented behavioral alterations. Among the neurochemical consequences of this manipulation in rats are increased hippocampal 5- HT2A receptor density, increased stress-induced HPA axis responsiveness, increased regional CRF concentrations in the CNS, increased CRF mRNA expression, and decreased glucocorticoid receptor density in hippocampus and frontal cortex. The behavioral consequences of the maternal separation stress include increased fear/anxiety behaviors and a pronounced preference for alcohol. All of these neurochemical and behavioral manifestations of maternal separation in adult rats are reversed by chronic treatment with paroxetine, a specific serotonin reuptake inhibitor. VFD monkeys exhibit altered endocrine responses to serotonergic challenge, CSF 5-HIAA alterations, and increased CSF CRF concentrations. Therefore, we propose to characterize the serotonergic systems of both models in detail, including developmental ontogeny, directly testing the role of increased 5-HT2A receptor function in mediating the phenotype, and response to antidepressants. We also propose multiple interactions with the different components of the Center including both basic science and clinical projects as well as all of the Cores. Our pilot data supports the hypothesis that serotonergic dysfunction is a central feature of the phenotypes displayed by each proposed model; and that alterations in markers of serotonergic activity will also be found in the two clinical projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prenatal atypical antipsychotic exposure
-
批准号:8411507
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:9284284
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:9069456
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:8843911
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Prenatal atypical antipsychotic exposure
-
批准号:8675273
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2013
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Biological Consequences of Prenatal Stress and/or Antidep
-
批准号:8111196
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2010
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Secondary Research Project: Monoamine Transporter Occupancy
-
批准号:8119601
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2010
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Research Methods Core
-
批准号:8119603
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2010
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Secondary Research Project: Monoamine Transporter Occupancy
-
批准号:7892513
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2009
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Research Methods Core
-
批准号:7892515
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2009
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Biological Consequences of Prenatal Stress and/or Antidep
-
批准号:7931869
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2009
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Serotoninergic systems
-
批准号:6341042
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2000
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
Serotoninergic systems
-
批准号:6259200
-
项目类别:
-
资助金额:$23.19万
-
财政年份:1999
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
NEUROCHEMICAL PATHOLOGY OF HUMAN COCAINE ABUSE
-
批准号:2122773
-
项目类别:
-
资助金额:$28.34万
-
财政年份:1995
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
NEUROCHEMICAL PATHOLOGY OF HUMAN COCAINE ABUSE
-
批准号:2430051
-
项目类别:
-
资助金额:$28.12万
-
财政年份:1995
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2121375
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2121372
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2121374
-
项目类别:
-
资助金额:$10.88万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2770093
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
CORTICOTROPIN RELEASING FACTOR AND BENZODIAZEPINES
-
批准号:2517921
-
项目类别:
-
资助金额:$10.46万
-
财政年份:1994
-
负责人:MICHAEL JOSEPH OWENS
-
依托单位:
海外基金